4 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow Thyroid Eye Disease: new trials by email Literature Review of Thyroid Eye Disease trials Research Report on Thyroid Eye Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ZB001 in Chinese Patients With Thyroid Eye Disease ZB001 for injection - Thyroid Eye Disease | Phase 1 | Completed | Zenas BioPharma (USA), LLC | 17 | 2023-05-10 | 2025-04-11 |
| Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) lonigutamab, Placebo - Thyroid Eye Disease | Phase 1 / Phase 2 | Completed | ACELYRIN Inc. | 31 | 2023-02-14 | 2025-07-01 |
| A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease Teprotumumab - Thyroid Eye Disease | Phase 1 | Completed | Amgen | 16 | 2022-07-14 | 2024-06-21 |
| A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease LASN01, Placebo - Pulmonary Fibrosis, Thyroid Eye Disease | Phase 1 / Phase 2 | Completed | Lassen Therapeutics 1 PTY LTD | 75 | 2022-06-06 | 2024-12-30 |
Graves Ophthalmopathy (4) · Pulmonary Fibrosis (1)
Autoimmune Diseases (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Endocrine System Diseases (4) · Exophthalmos (4) · Eye Diseases (4) · Eye Diseases, Hereditary (4) · Genetic Diseases, Inborn (4) · Goiter (4) · Graves Disease (4) · Hyperthyroidism (4) · Immune System Diseases (4) · Orbital Diseases (4) · Thyroid Diseases (4) · Fibrosis (1) · Lung Diseases (1)
Injections (1) · teprotumumab (1)
ACELYRIN Inc. (1) · Amgen (1) · Lassen Therapeutics 1 PTY LTD (1) · Zenas BioPharma (USA), LLC (1)
Australia (2) · United States (2) · China (1) · Hong Kong (1)